Profil
Sven Arne Andréasson currently works at Operations Leadership Oil AB, as Chairman, Cellastra, Inc., as Vice Chairman, Mendus AB, as Independent Director from 2020, Galenos SRL, as Director from 2014, and Stefan Forsberg Consulting AB, as Deputy Director.
Mr. Andréasson also formerly worked at Active Biotech AB, as Co-Chief Executive Officer from 1999 to 2008, Novavax AB, as Chief Executive Officer from 2012 to 2013, Kabivitrum AB, as Chief Executive Officer-Biopharma Division, Beta-Cell NV, as Chief Executive Officer from 2008 to 2012, Unibioscreen SA, as Chairman, Cantargia AB, as Chairman, TiGenix NV, as Independent Director from 2009 to 2011, ERYTech Pharma SA, as Independent Director from 2013 to 2023, SwedenBIO Service AB, as Director, Mendus AB, as Independent Director from 2013 to 2016, Advet AB, as Director, Advet Production AB, as Director, Pharmacia AB, as President & Vice President in 1999, Pharmacia SAS, as President from 1994 to 1999, Kabi Pharmacia, as President, Sista versen 26366 AB, as President, Pharmacia Arzneimittel GmbH, as President, Kabipharmacia International, as President, and Novavax, Inc., as Senior Vice President-Corporate Development from 2014 to 2023.
Mr. Andréasson received his undergraduate degree from Stockholm School of Economics.
Aktive Positionen von Sven Arne Andréasson
| Unternehmen | Position | Beginn |
|---|---|---|
| MENDUS AB | Direktor/Vorstandsmitglied | 01.01.2020 |
Operations Leadership Oil AB | Vorsitzender | 15.10.2010 |
Cellastra, Inc.
Cellastra, Inc. BiotechnologyHealth Technology Operates as biotech company | Direktor/Vorstandsmitglied | - |
Galenos SRL | Direktor/Vorstandsmitglied | 01.01.2014 |
Stefan Forsberg Consulting AB | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Sven Arne Andréasson
| Unternehmen | Position | Ende |
|---|---|---|
ERYTech Pharma SA
ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology Develops medicinal products for orphan oncology and rare diseases | Direktor/Vorstandsmitglied | 23.06.2023 |
| NOVAVAX, INC. | Corporate Officer/Principal | 01.05.2023 |
| MENDUS AB | Direktor/Vorstandsmitglied | 26.05.2016 |
Novavax AB
Novavax AB Pharmaceuticals: GenericHealth Technology Develops, manufactures, and sells vaccine adjuvants | Vorstandsvorsitzender | 01.11.2013 |
| ░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Sven Arne Andréasson
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 24 |
|---|---|
Novavax, Inc.
Novavax, Inc. BiotechnologyHealth Technology Engages in development of novel recombinant vaccines | Health Technology |
TiGenix NV
TiGenix NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on developing and commercializing novel therapeutic | Health Technology |
Active Biotech AB
Active Biotech AB BiotechnologyHealth Technology Develops drugs for cancer, neurodegenerative and inflammatory diseases | Health Technology |
Pharmacia AB
Pharmacia AB Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Health Technology |
Novavax AB
Novavax AB Pharmaceuticals: GenericHealth Technology Develops, manufactures, and sells vaccine adjuvants | Health Technology |
Stockholm School of Economics
Stockholm School of Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ERYTech Pharma SA
ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology Develops medicinal products for orphan oncology and rare diseases | Health Technology |
Unibioscreen SA
Unibioscreen SA Pharmaceuticals: MajorHealth Technology Discovers and develops oncology drugs | Health Technology |
Pharmacia SAS | |
Kabi Pharmacia | |
Kabivitrum AB | |
SwedenBIO Service AB
SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services Provides educational services | Commercial Services |
Cantargia AB
Cantargia AB Pharmaceuticals: MajorHealth Technology Creates and develops antibody therapeutics for the treatment of leukemia | Health Technology |
Sista versen 26366 AB
Sista versen 26366 AB Pharmaceuticals: MajorHealth Technology Discovers treatments for inflammatory disorders | Health Technology |
Beta-Cell NV
Beta-Cell NV Miscellaneous Commercial ServicesCommercial Services Engages in translating diabetes research | Commercial Services |
Operations Leadership Oil AB | |
Mendus AB
Mendus AB BiotechnologyHealth Technology Develops immunotherapies for therapeutic treatment of cancer | Health Technology |
Cellastra, Inc.
Cellastra, Inc. BiotechnologyHealth Technology Operates as biotech company | Health Technology |
Galenos SRL | |
Stefan Forsberg Consulting AB | |
Advet AB | |
Advet Production AB | |
Pharmacia Arzneimittel GmbH
Pharmacia Arzneimittel GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Kabipharmacia International
Kabipharmacia International Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
















